Results of a 5-year prospective surveillance study of antibiotic resistance among Salmonella enterica isolates and ceftriaxone therapy among children hospitalized for acute diarrhea

Clinical Therapeutics

Volumn 24, Issue 10, 2002, Pages 1585-1594

  Chiappini, Elena ^a   Galli, Luisa ^a   Pecile, Patrizia ^b   Vierucci, Alberto ^a   De Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Antimicrobial resistance; Ceftriaxone; Children; Ciprofloxacin; Salmonella

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NEOMYCIN; TETRACYCLINE;

ACUTE DIARRHEA; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CHILD; DRUG EFFICACY; FECES CULTURE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE;

EID: 0036811244     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)80062-5     Document Type: Article

References (26)

1. Rabsch W, Tschape H, Baumler AJ. Nontyphoidal salmonellosis: Emerging problems. Microbes Infect. 2001;3:237-247.
2. White DG, Zhao S, Sudler R, et al. The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med. 2001;345:1147-1154.
3. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331-351.
4. Salmonella infections. In: Pickering LK, ed. Red Book: Report of the Committee on Infectious Diseases. 25th Ed. Elk Grove Village, III: American Academy of Pediatrics, Committee on Infectious Diseases; 2000:501-506.
5. Price EH, de Louvois J, Workman MR. Antibiotics for Salmonella meningitis in children. J Antimicrob Chemother. 2000;46:653-655.
6. Walker-Smith JA, Sandhu BK, Isolauri E, et al. Guidelines prepared by the ESPGAN Working Group on Acute Diarrhea. Recommendations for feeding in childhood gastroenteritis. European Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1997;24:619-520.
7. Gray LD. Escherichia, Salmonella, Shigella and Yersinia. In: Murray PK, Baron EJ, Pfaller MA, et al, eds. Manual of Clinical Microbiology. 6th Ed. Washington, DC: American Society for Microbiology Press; 1995:450-456.
8. Brenner FW, Villar RG, Angulo FJ, et al. Salmonella nomenclature. J Clin Microbiol. 2000;38:2465-2467.
9. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A4. 4th Ed. Wayne, Pa: NCCLS; 1997.
10. Nastasi A, Mammina C, Cannova L. Antimicrobial resistance in Salmonella enteritidis, southern Italy, 1990-1998. Emerg Infect Dis. 2000;6:401-403.
11. Breuil J, Brisabois A, Casin I, et al. Antibiotic resistance in salmonellae isolated from humans and animals in France: Comparative data from 1994 and 1997. J Antimicrob Chemother. 2000;46:965-971.
12. Cormican M, Butler C, Morris D, et al. Antibiotic resistance amongst Salmonella enterica species isolated in the Republic of Ireland. J Antimicrob Chemother. 1998;42:116-118.
13. Threlfall EJ. Epidemic Salmonella typhimurium DT 104 - A truly international multiresistant clone. J Antimicrob Chemother. 2000;46:7-10.
14. Cruchaga S, Echeita A, Aladuena A, et al. Antimicrobial resistance in salmonellae from humans, food and animals in Spain in 1998. J Antimicrob Chemother. 2001;47:315-321.
15. Casini T, Cristiano R, Salvi G, et al. Evaluation of pediatric patients hospitalized for acute diarrhea from 1990 to 1996. Pediatr Med Chir. 1997;19:31-35 [in Italian].
16. Olsen SJ, Bishop R, Brenner FW, et al. The changing epidemiology of Salmonella: Trends in serotypes isolated from humans in the United States, 1987-1997. J Infect Dis. 2001;183:753-761.
17. Gorbach SL. Antimicrobial use in animal feed - Time to stop. N Engl J Med. 2001;345:1202-1203.
18. Proposal for a regulation of the European Parliament and of the Council on additives for use in animal nutrition. Official J Eur Communities. 2002;45:10-21. Report C-203/E03.
19. Threlfall EJ, Ward LR, Skinner JA, Rowe B. Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: A comparison of data for 1994 and 1996. Microb Drug Resist. 1997;3:263-266.
20. Tassios PT, Markogiannakis A, Vatopoulos AC, et al. Molecular epidemiology of antibiotic resistance of Salmonella enteritidis during a 7-year period in Greece. J Clin Microbiol. 1997;35:1316-1321.
21. Dunne EF, Fey PD, Kludt P, et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA. 2000;284:3151-3156.
22. Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: Worldwide clinical experience based on compassionate use - Safety report. Pediatr Infect Dis J. 1997;16:127-129, 160-162.
23. Leibovitz E, Janco J, Piglansky L, et al. Oral ciprofloxacin vs intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J. 2000;19:1060-1067.
24. Cheesbrough JS, Mwema FI, Green SD, Tillotson GS. Quinolones in children with invasive salmonellosis. Lancet. 1991;338:127.
25. Acheson DW, Sears CL. Dangers of empiric oral ciprofloxacin in the treatment of acute inflammatory diarrhea in children. Pediatr Infect Dis J. 2001;20:817-818.
26. Fisher I. Salm/Enter-Net records a resurgence in Salmonella enteritidis infection through the European Union. Euro Surveill. 1997;12:4-6.